BCM
PDLI

Basso Capital Management’s PDL BioPharma, Inc. PDLI Stock Holding History

Basso Capital Management’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-100,000
Closed -$503K – 171
2015
Q3 		$503K Buy
100,000
+50,000
+100% +$287K 0.08% 98
2015
Q2 		$322K Hold
50,000
– – 0.05% 93
2015
Q1 		$352K Sell
50,000
-100,000
-67% -$724K 0.05% 95
2014
Q4 		$1.16M Buy
150,000
+50,000
+50% +$396K 0.18% 72
2014
Q3 		$747K Buy
+100,000
New +$928K 0.11% 78

Other funds holding PDLI

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Basso Capital Management's PDLI Position: Q3 2015 in Review

Basso Capital Management sold out of PDL BioPharma, Inc. (PDLI) in Q3 2015, closing a stake of 65,082 shares — an estimated $373K sold.

Basso Capital Management first reported a position in PDLI in Q1 2014 and held it in 6 quarters. The position peaked at $2.99M in Q1 2014. 213 funds tracked by Wall St. Rank hold PDLI as of Q3 2015.

  • Basso Capital Management reported no remaining PDL BioPharma, Inc. position as of Q3 2015 after selling out during the quarter.
  • Basso Capital Management sold 65,082 PDL BioPharma, Inc. shares in Q3 2015, an estimated $373K.
  • Basso Capital Management first reported a position in PDL BioPharma, Inc. in Q1 2014 and held it in 6 quarters.
  • Basso Capital Management's PDL BioPharma, Inc. position peaked at $2.99M in Q1 2014.
  • 213 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q3 2015.

Based on Basso Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.